Alievio logo — Developing the first personalized glaucoma treatment to stop...

Alievio

Developing the first personalized glaucoma treatment to stop vision loss.

Founded 2010 United States United States 4 employees Series A Total: $11.87M Health Care, Medical Devices

General Information

Company Name Alievio
Founded Year 2010
Location United States United States
Employees 4
Industries Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Alievio. To contact Alievio, visit alievio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Alievio

Alievio is a health care startup founded in 2010 in the United States. With the slogan "Developing the first personalized glaucoma treatment to stop vision loss," the company aims to provide relief to patients suffering from late stage glaucoma through innovative medical devices.

The company recently received a $5.70M Series A investment on 10 April 2018. The investment was led by a consortium of prominent investors including InFocus Capital Partners, Pilot Mountain Ventures, V Capital, IMAF Coastal Plain, Triangle Angel Partners, and Triangle Venture Alliance.

Alievio's dedication to addressing an unmet need in the glaucoma treatment space, combined with the significant backing it has received from established investors, positions the company as a promising player in the health care innovation landscape.

Taxonomy: glaucoma treatment, medical device company, innovative therapy, vision loss prevention, ophthalmology, eye care, patient relief, North Carolina, progression prevention

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $5.70M 6
InFocus Capital Partners, Pilot Mountain Ventures +4
10 Apr 2018
Series A $3.00M 3
Carolina Angel Network, Duke Angel Network +1
17 Nov 2017
Seed Round $1.30M 3
Charlotte Angel Fund, Pilot Mountain Ventures +1
14 Apr 2016
Grant $1.37M 1
National Science Foundation
17 Feb 2016
Seed Round $175.00K -
28 Apr 2015
Grant $180.00K 1
National Science Foundation
25 Nov 2014
Grant $149.98K 1
National Science Foundation
18 Dec 2012

Alievio Alternatives & Competitors

View All Alternatives
Alievio vs

Innovative solutions for myopia prevention and control, vision protection, low vision aids, and dry...

Seed
Health Care, Medical Devices
Alievio vs

Innovative solutions for presbyopia treatment, enabling clear vision with KAMRA inlays and precise s...

Venture round
Health Care, Medical Devices
Alievio vs

Pioneering groundbreaking medical solutions for vision disorders, with a focus on presbyopia treatme...

Biotechnology, Health Care

FAQ About Alievio

Developing the first personalized glaucoma treatment to stop vision loss.
Alievio was founded in 2010.
Alievio is headquartered in United States.
Alievio operates in Health Care and Medical Devices. Its work centres on glaucoma treatment, medical device company, innovative therapy and vision loss prevention.
Alievio has approximately 4 employees.
Alievio has completed 7 funding rounds, raising a total of $11.87M. The latest funding stage is Series A.
Top alternatives and competitors to Alievio include Artheia, AcuFocus, Refocus Group, ThermaMEDx, LLC, LENTECHS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alievio and Artheia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Alievio, https://bouncewatch.com/company/alievio, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes